Eli Lilly And Co vs Vanguard Growth Index Fund ETF — how do they compare? Eli Lilly And Co trades at $1,174.08 (market cap $1.02T), while Vanguard Growth Index Fund ETF trades at $86.16. The key difference: Eli Lilly And Co pays a 0.6% dividend while Vanguard Growth Index Fund ETF pays none. Which is the better fit depends on your goals.
| LLY | VUG | |
|---|---|---|
Market Cap | $1.02T | — |
Sector | Health | Sector/Thematic |
52-Week High | $1.24K | $90.29 |
52-Week Low | $625.65 | $70.00 |
Enterprise Value | $1.06T | — |
Dividend Yield | 0.6% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VUG trades at $85.32, up 0.06% with a bearish technical signal from moving averages. The ETF's low expense ratio of 0.03% and strong historical returns, including a 411% total return over the past decade per The Motley Fool (2026-07-12), highlight its cost efficiency. Recent news emphasizes its growth focus and tech-heavy holdings, with a stock split executed on 21 April 2026. Support levels are clustered around $84-$85, indicating potential near-term stability.
Outlook remains positive for long-term investors due to VUG's low-cost structure and exposure to high-growth U.S. large-cap stocks. Risks include high concentration in technology sectors and market volatility. Analyst sentiment is generally favorable, supporting a buy-and-hold strategy for wealth accumulation.
Trailing returns across standard periods
Latest headlines on both assets
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.
Read more on VUG →